Median of all reaction times for males and females [cs]
Project: p50_david_dietz
3 significantly associated models · 3 unique genes
# | chr | p0 | p1 | # assoc genes | # joint models | best TWAS P | best SNP P | cond SNP P | % var exp | joint genes |
---|---|---|---|---|---|---|---|---|---|---|
1 | 7 | 36928280 | 39249627 | 2 | 1 | 1.3e-07 | 1.6e-08 | 1 | 100 | Nts |
2 | 7 | 40107444 | 41504493 | 1 | 1 | 1.1e-08 | 6.0e-09 | 1 | 100 | Tmtc2 |
p0: physical position of the start of the locus. p1: physical position of the end of the locus. # joint models: number of models selected by step-wise conditional analysis.
Trait | chisq ratio | # genes+ | # genes++ | % genes++ | corr | corr P | genes |
---|---|---|---|---|---|---|---|
body_g | 1.7 | 2 | 0 | 0 | 0 | 1 | Nts Slc6a15 |
reaction_time_corr | 7.1 | 3 | 0 | 0 | 0 | 1 | Nts Tmtc2 Slc6a15 |
reaction_time_leftcorr | 7.1 | 3 | 0 | 0 | 0 | 1 | Nts Tmtc2 Slc6a15 |
tautz: manual_spc7 | 4.2 | 1 | 0 | 0 | 0 | 1 | Slc6a15 |
tautz: manual_mpc4 | 10.7 | 2 | 0 | 0 | 0 | 1 | Nts Slc6a15 |
tautz: manual_mpc5 | 7.9 | 3 | 0 | 0 | 0 | 1 | Nts Tmtc2 Slc6a15 |
tautz: manual_spc10 | 4.7 | 2 | 0 | 0 | 0 | 1 | Tmtc2 Slc6a15 |
tautz: manual_mpc2 | 6.1 | 2 | 0 | 0 | 0 | 1 | Nts Slc6a15 |
tautz: manual_spc16 | 5.7 | 2 | 0 | 0 | 0 | 1 | Nts Slc6a15 |
tautz: manual_spc5 | 5.2 | 1 | 0 | 0 | 0 | 1 | Tmtc2 |
tautz: manual_mpc11 | 4.7 | 1 | 0 | 0 | 0 | 1 | Slc6a15 |
chisq ratio: Average Chi2 statistic for the selected genes in the secondary trait, divided by the average statistic for all genes in the secondary trait. # genes+: Shared significant genes at Bonferroni correction. # genes++: Shared significant genes at transcriptome-wide significance. % genes++: Number of [++] genes as a percentage of primary trait’s total joint genes. corr: Correlation of effect sizes across the [+] genes.
tissue | modality | # hits | % hits/tests | avg chisq |
---|---|---|---|---|
Adipose | alternative polyA | 0 | 0.000 | 1.31 |
Adipose | alternative TSS | 0 | 0.000 | 1.25 |
Adipose | gene expression | 0 | 0.000 | 1.34 |
Adipose | isoform ratio | 0 | 0.000 | 1.37 |
Adipose | intron excision ratio | 0 | 0.000 | 1.41 |
Adipose | mRNA stability | 0 | 0.000 | 1.33 |
BLA | alternative polyA | 0 | 0.000 | 1.31 |
BLA | alternative TSS | 0 | 0.000 | 1.18 |
BLA | gene expression | 0 | 0.000 | 1.35 |
BLA | isoform ratio | 0 | 0.000 | 1.39 |
BLA | intron excision ratio | 0 | 0.000 | 1.38 |
BLA | mRNA stability | 0 | 0.000 | 1.42 |
Brain | alternative polyA | 0 | 0.000 | 1.36 |
Brain | alternative TSS | 0 | 0.000 | 1.33 |
Brain | gene expression | 0 | 0.000 | 1.37 |
Brain | isoform ratio | 0 | 0.000 | 1.37 |
Brain | intron excision ratio | 0 | 0.000 | 1.44 |
Brain | mRNA stability | 0 | 0.000 | 1.40 |
Eye | alternative polyA | 0 | 0.000 | 1.40 |
Eye | alternative TSS | 0 | 0.000 | 0.85 |
Eye | gene expression | 0 | 0.000 | 1.42 |
Eye | isoform ratio | 0 | 0.000 | 1.28 |
Eye | intron excision ratio | 0 | 0.000 | 1.43 |
Eye | mRNA stability | 0 | 0.000 | 1.25 |
IL | alternative polyA | 0 | 0.000 | 1.31 |
IL | alternative TSS | 0 | 0.000 | 1.29 |
IL | gene expression | 1 | 0.027 | 1.31 |
IL | isoform ratio | 0 | 0.000 | 1.37 |
IL | intron excision ratio | 0 | 0.000 | 1.35 |
IL | mRNA stability | 0 | 0.000 | 1.47 |
LHb | alternative polyA | 0 | 0.000 | 1.21 |
LHb | alternative TSS | 0 | 0.000 | 1.42 |
LHb | gene expression | 1 | 0.031 | 1.31 |
LHb | isoform ratio | 0 | 0.000 | 1.52 |
LHb | intron excision ratio | 0 | 0.000 | 1.44 |
LHb | mRNA stability | 0 | 0.000 | 1.45 |
Liver | alternative polyA | 0 | 0.000 | 1.32 |
Liver | alternative TSS | 0 | 0.000 | 1.28 |
Liver | gene expression | 0 | 0.000 | 1.33 |
Liver | isoform ratio | 0 | 0.000 | 1.35 |
Liver | intron excision ratio | 0 | 0.000 | 1.33 |
Liver | mRNA stability | 0 | 0.000 | 1.32 |
NAcc | alternative polyA | 0 | 0.000 | 1.27 |
NAcc | alternative TSS | 0 | 0.000 | 1.30 |
NAcc | gene expression | 0 | 0.000 | 1.32 |
NAcc | isoform ratio | 0 | 0.000 | 1.40 |
NAcc | intron excision ratio | 0 | 0.000 | 1.41 |
NAcc | mRNA stability | 0 | 0.000 | 1.44 |
NAcc2 | alternative polyA | 0 | 0.000 | 1.41 |
NAcc2 | alternative TSS | 0 | 0.000 | 1.28 |
NAcc2 | gene expression | 1 | 0.019 | 1.35 |
NAcc2 | isoform ratio | 0 | 0.000 | 1.42 |
NAcc2 | intron excision ratio | 0 | 0.000 | 1.44 |
NAcc2 | mRNA stability | 0 | 0.000 | 1.39 |
OFC | alternative polyA | 0 | 0.000 | 1.12 |
OFC | alternative TSS | 0 | 0.000 | 1.44 |
OFC | gene expression | 0 | 0.000 | 1.32 |
OFC | isoform ratio | 0 | 0.000 | 1.48 |
OFC | intron excision ratio | 0 | 0.000 | 1.41 |
OFC | mRNA stability | 0 | 0.000 | 1.42 |
PL | alternative polyA | 0 | 0.000 | 1.41 |
PL | alternative TSS | 0 | 0.000 | 1.51 |
PL | gene expression | 0 | 0.000 | 1.34 |
PL | isoform ratio | 0 | 0.000 | 1.35 |
PL | intron excision ratio | 0 | 0.000 | 1.28 |
PL | mRNA stability | 0 | 0.000 | 1.40 |
PL2 | alternative polyA | 0 | 0.000 | 1.26 |
PL2 | alternative TSS | 0 | 0.000 | 1.19 |
PL2 | gene expression | 0 | 0.000 | 1.34 |
PL2 | isoform ratio | 0 | 0.000 | 1.41 |
PL2 | intron excision ratio | 0 | 0.000 | 1.44 |
PL2 | mRNA stability | 0 | 0.000 | 1.37 |
avg chisq: Average Chi2 (squared Z-score) across all models in this panel for this trait.